School of Medicine collaboration on £13m PhD programme to tackle growing health issue of Multiple Long-Term Conditions
A consortium led by the University of Glasgow, in collaboration with the Universities of Dundee, Edinburgh and St Andrews, has been awarded £13.8m from Wellcome to support a new Multiple Long-Term Conditions (MLTCs) PhD programme for health professionals.
Multiple long-term conditions (MLTCs) are a growing global health challenge, associated with frailty, poorer quality of life, premature mortality and high healthcare utilisation. Despite this, research and clinical practice often remain focused on single diseases, leaving major gaps in understanding how conditions interact and how best to support people living with them.
The new programme is the only one of its kind globally, and the only Wellcome‑funded programme in Scotland. It will be led by Professor Frances Mair, Norie Miller Professor of General Practice at the University of Glasgow within the School of Health & Wellbeing.
Professor Colin McCowan will serve as a Director and lead for the programme at the University of St Andrews, alongside Deputy Director Professor Derek Sloan, with St Andrews hosting its component of the programme within the School of Medicine.
The MLTC PhD programme aims to train a new generation of researchers equipped to address the major challenges of MLTCs:
- identifying mechanisms and pathways underpinning development and progression
- understanding interactions between co‑existing mental and physical health conditions
- uncovering drivers of effective prevention and management, including the role of health inequalities
Researchers will receive interdisciplinary training spanning experimental medicine, data analytics and qualitative approaches, enabling them to connect biological mechanisms with real‑world complexity.
Professor Colin McCowan said: “This programme is a successful renewal that has already seen nine clinical Fellows join the University of St Andrews. We look forward to supporting another cohort of clinical PhD Fellows to explore how MLTCs affect people’s lives and how health services can better support individuals living with MLTCs. Working in collaboration with our three Scottish university partners and international collaborators, we aim to build research that makes a meaningful difference to patient care.”
Ben Murton, Head of Early Career and Career Development Researchers at Wellcome, highlighted the importance of supporting healthcare professionals in research careers, noting that these programmes provide essential qualifications and a platform for world‑class discovery.
The programme will begin advertising across the UK soon, with the first cohort commencing in 2027.